Cincinnati, OH, United States of America

Patrick Tso


 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 147(Granted Patents)


Location History:

  • Loveland, OH (US) (2010)
  • Cincinnati, OH (US) (2000 - 2019)

Company Filing History:


Years Active: 2000-2019

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Patrick Tso in Diabetes Treatment

Introduction

Patrick Tso is an accomplished inventor based in Cincinnati, OH, with a significant contribution to the field of diabetes treatment. He holds a total of 8 patents, showcasing his dedication to advancing medical science and improving patient outcomes.

Latest Patents

Among his latest innovations are two notable patents. The first patent, titled "Method of treating hyperglycemic disorders using apolipoprotein AIV," discloses methods for treating hyperglycemia disorders in subjects. This includes administering an effective amount of apolipoprotein A-IV to restore glucose tolerance and lower blood glucose levels in individuals with various hyperglycemic disorders. The second patent, "Method of treating diabetes using non-glycosylated apolipoprotein A-IV," focuses on treating type two diabetes mellitus. This method utilizes non-glycosylated apolipoprotein A-IV produced by a protein expression system, such as a bacterial expression system, to achieve similar therapeutic effects.

Career Highlights

Patrick Tso has worked with reputable organizations, including the University of Cincinnati and Abbott Laboratories Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Sean Davidson and Fei Wang, who have played a role in his innovative projects and research endeavors.

Conclusion

Patrick Tso's contributions to diabetes treatment through his patents and collaborations highlight his commitment to medical innovation. His work continues to pave the way for advancements in the management of hyperglycemic disorders and diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…